FOR LABORATORY RESEARCH PURPOSES ONLY. This compound has not received FDA approval. All information shown is drawn from published laboratory research for educational purposes
$700.00
Lost, stolen, or damaged? We replace it, on us.
Pick your speed at checkout.
Before you continue
This site sells research products exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
GLP-2 / BPC-157 is a two-compound research blend supplied by Peppy Peptides for laboratory research use only. With this blend, laboratories can examine two distinct peptide-signaling systems in a single formulation.
The blend combines two peptides. The first is GLP-2, a synthetic dual GIP/GLP-1 receptor agonist. The second is BPC-157, a gastric-derived peptide fragment that appears in peptide-signaling literature.
GLP-2 / BPC-157 is studied for interaction with GIP and GLP-1 receptor signaling and with pathways associated with peptide-signaling in laboratory models. Researchers working with the blend in vitro and in preclinical models examine:
GLP-2 / BPC-157 is suited to combination-peptide study designs, in which researchers examine a dual GIP/GLP-1 receptor agonist alongside a second peptide within the same experimental design. This supports assays that require concurrent exposure to both compounds.
The blend is also relevant to peptide-interaction modeling, formulation-stability research on multi-peptide research products, and assay-validation work comparing blended and single-compound protocols. Cell-biology, biochemistry and comparative-signaling laboratories may study it as part of multi-pathway characterization.
GLP-2 / BPC-157 is a two-compound research blend studied for interaction with GIP and GLP-1 receptor signaling and with peptide-signaling pathways in laboratory models.
A single formulation lets researchers examine both signaling systems concurrently and compare blended protocols with single-compound protocols.
Published laboratory research on GLP-2 and BPC-157 is indexed on PubMed.
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. This compound has not received FDA approval. All information shown is drawn from clinical studies for educational purposes.
Researcher favourites
Price range: $125.00 through $175.00
Price range: $150.00 through $650.00
Price range: $125.00 through $700.00
$150.00
$175.00
Compound details
Molecular profile
Storage requirements
Store lyophilized at −20°C for long-term stability; avoid repeated freeze-thaw cycles; protect from light and moisture
Refrigerate at 2–8°C after reconstitution; use within 4–6 weeks
Published literature
3 peer-reviewed publications indexed on PubMed. Listed for reference only; inclusion does not imply any use, effect or endorsement.
CURR PHARM DES · 2014
Seiwerth S, Brcic L, Vuletic LB, et al. Curr Pharm Des. 2014;20(7):1121-5. doi:10.2174/13816128113199990421
Reviewed published laboratory and preclinical research on BPC 157 in relation to blood-vessel biology.
CURR PHARM DES · 2014
Stable gastric pentadecapeptide BPC 157-NO-system relation
Sikiric P, Seiwerth S, Rucman R, et al. Curr Pharm Des. 2014;20(7):1126-35. doi:10.2174/13816128113190990411
Reviewed research on the relationship between BPC 157 and the nitric oxide (NO) system.
NEURAL REGEN RES · 2022
Pentadecapeptide BPC 157 and the central nervous system
Vukojevic J, Milavić M, Perović D, et al. Neural Regen Res. 2022;17(3):482-487. doi:10.4103/1673-5374.320969
Reviewed preclinical research on BPC 157 in relation to the central nervous system.
